Retrospective Analysis of Rhabdomyosarcoma (RMS) in Children in a Single Center

Overview

Journal Thorac Cancer

Specialties Oncology
Pulmonary Medicine

Date 2018 Aug 1

PMID 30062849

Authors

Meng Li

Xiuju Bian

Rui Jing

Aijun Zhang

Nianzheng Sun

Xiuli Ju

Fuhai Li

Affiliations

Soon will be listed here.

Abstract

Background: This study was conducted to explore the influence of clinical features of rhabdomyosarcoma (RMS) and a refined therapeutic protocol on the therapeutic efficacy and prognosis in children in the past five years.

Methods: Forty children diagnosed with RMS were retrospectively studied, using a version of the therapeutic protocol refined by Shanghai Children's Medical Center (version 2009.9.1). The patients' demographic characteristics, clinical manifestations, pathological features, therapeutic efficacy, and prognosis were analyzed.

Results: Of the 40 children, 17 abandoned treatment. Of the remaining 23 cases, two children were rated as low risk, 12 as medium risk, and nine as high risk, and all received treatment. Patients in the low and medium-risk groups had better prognosis than those in the high-risk group, and treated patients had higher survival rates and longer survival than untreated patients.

Conclusion: Children with RMS should be treated positively. Combined treatment shows better therapeutic efficacy and prognosis. The refined therapeutic protocol seems more effective than the standard treatment, with a significant impact on long-term RMS prognosis.

References

Yuan G, Yao H, Li X, Li H, Wu L . [Analysis of 13 cases of rhabdomyosarcoma in the female genital tract]. Zhonghua Fu Chan Ke Za Zhi. 2016; 51(4):264-9. DOI: 10.3760/cma.j.issn.0529-567X.2016.04.005. View

Rogers T, Minard-Colin V, Cozic N, Jenney M, Merks J, Gallego S . Paratesticular rhabdomyosarcoma in children and adolescents-Outcome and patterns of relapse when utilizing a nonsurgical strategy for lymph node staging: Report from the International Society of Paediatric Oncology (SIOP) Malignant Mesenchymal.... Pediatr Blood Cancer. 2017; 64(9). DOI: 10.1002/pbc.26486. View

Punyko J, Mertens A, Baker K, Ness K, Robison L, Gurney J . Long-term survival probabilities for childhood rhabdomyosarcoma. A population-based evaluation. Cancer. 2005; 103(7):1475-83. DOI: 10.1002/cncr.20929. View

Orbach D, Mosseri V, Gallego S, Kelsey A, Devalck C, Brenann B . Nonparameningeal head and neck rhabdomyosarcoma in children and adolescents: Lessons from the consecutive International Society of Pediatric Oncology Malignant Mesenchymal Tumor studies. Head Neck. 2016; 39(1):24-31. DOI: 10.1002/hed.24547. View

Iatrou I, Theologie-Lygidakis N, Schoinohoriti O, Tzermpos F, Vessala A . Rhabdomyosarcoma of the maxillofacial region in children and adolescents: Report of 9 cases and literature review. J Craniomaxillofac Surg. 2017; 45(6):831-838. DOI: 10.1016/j.jcms.2017.03.005. View

Raney R, Walterhouse D, Meza J, Andrassy R, Breneman J, Crist W . Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from.... J Clin Oncol. 2011; 29(10):1312-8. PMC: 3083999. DOI: 10.1200/JCO.2010.30.4469. View

Belyea B, Kephart J, Blum J, Kirsch D, Linardic C . Embryonic signaling pathways and rhabdomyosarcoma: contributions to cancer development and opportunities for therapeutic targeting. Sarcoma. 2012; 2012():406239. PMC: 3350847. DOI: 10.1155/2012/406239. View

Yang J, Yang J, Yu M, Yuan Z, Cao D, Keng S . Clinical Study on Female Genital Tract Rhabdomyosarcoma in Childhood: Changes During 20 Years in One Center. Int J Gynecol Cancer. 2016; 27(2):311-314. DOI: 10.1097/IGC.0000000000000872. View

Yuan G, Yao H, Li X, Li H, Wu L . Stage 1 embryonal rhabdomyosarcoma of the female genital tract: a retrospective clinical study of nine cases. World J Surg Oncol. 2017; 15(1):42. PMC: 5297139. DOI: 10.1186/s12957-017-1110-y. View

10.

Ma X, Huang D, Zhao W, Sun L, Xiong H, Zhang Y . Clinical characteristics and prognosis of childhood rhabdomyosarcoma: a ten-year retrospective multicenter study. Int J Clin Exp Med. 2016; 8(10):17196-205. PMC: 4694212. View

11.

Hammond W, Farber B, Price A, Wolden S, Heaton T, Wexler L . Paratesticular rhabdomyosarcoma: Importance of initial therapy. J Pediatr Surg. 2016; 52(2):304-308. PMC: 5253324. DOI: 10.1016/j.jpedsurg.2016.11.027. View

12.

Walterhouse D, Pappo A, Meza J, Breneman J, Hayes-Jordan A, Parham D . Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Cancer. 2017; 123(12):2368-2375. PMC: 5662934. DOI: 10.1002/cncr.30613. View

13.

Choi P, Iwanaga J, Tubbs R, Yilmaz E . Surgical Interventions for Advanced Parameningeal Rhabdomyosarcoma of Children and Adolescents. Cureus. 2018; 10(1):e2045. PMC: 5844646. DOI: 10.7759/cureus.2045. View